Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cytokinetics, Incorporated CYTK

Set alert

Price alert · CYTK

All alert types
62.67 USD +0.64 +1.03%

As of Nov 3, 11:59 AM ET

Bid
62.65 × 1
Ask
62.77 × 1
62.05 Day range 64.37
58.05 52-week range 88.31
YTD
-1.37%
1 year
+4.40%
Open
62.74
Prev close
62.03
Mkt cap
8.72B
Vol
621.75K
Avg vol
1.90M
EPS
-7.22
P/E
0.00
Div yield
0.00%
More statistics
Low
62.05
High
64.37
Forward P/E
-14.09
Beta
0.47
Short ratio
8.18
Inst. own
126.08%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
67.50
200-d avg
70.08
1y target
107.39

1D chart

Chart tools
Interval
1m5m15m30m

Signals (17)
NameTimeAgo
SMA: Bullish11:53 AM6 minutes ago
SMA: Bearish11:52 AM7 minutes ago
SMA: Bullish11:50 AM9 minutes ago
MACD: Buy Signal11:39 AM20 minutes ago
RSI: Oversold11:33 AM26 minutes ago
RSI: Oversold11:22 AM37 minutes ago
SMA: Bearish11:03 AM56 minutes ago
SMA: Bearish10:54 AM1 hour ago
MACD: Sell Signal10:46 AM1 hour ago
RSI: Overbought10:35 AM1 hour ago
MACD: Buy Signal10:34 AM1 hour ago
MACD: Sell Signal10:25 AM1 hour ago
SMA: Bullish10:05 AM1 hour ago
MACD: Buy Signal10:05 AM1 hour ago
MACD: Sell Signal10:04 AM1 hour ago
SMA: Bearish10:02 AM1 hour ago
RSI: Overbought9:45 AM2 hours ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 107.39 +71.4% upside
Target (low)
81.00
Target (mean)
107.39
Target (high)
140.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy13
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 22
  • 1 month ago 22
  • 2 months ago 22

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CYTK analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.41-1.65 – -1.10-1.54+8.8%41.60M+2048.8%18
Next quarter-1.39-1.76 – -1.02-1.50+7.4%62.59M+252.5%18
Current year-5.88-6.38 – -4.75-6.54+10.2%158.49M+80.0%18
Next year-4.40-5.90 – -3.14-5.88+25.1%430.63M+171.7%18

Upgrades and downgrades

The latest rating changes

CYTK analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 16, 2026William BlairInitiated—Outperform
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Aug 31, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2026BarclaysMaintainedOverweightOverweight
Aug 13, 2026JP MorganMaintainedOverweightOverweight
Aug 10, 2026Truist SecuritiesMaintainedBuyBuy
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Aug 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
Aug 7, 2026NeedhamMaintainedBuyBuy
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 29, 2026UBSUpgradeNeutralBuy
Jun 24, 2026MizuhoMaintainedOutperformOutperform
Jun 17, 2026NeedhamReiteratedBuyBuy
May 19, 2026CitigroupInitiated—Buy
May 12, 2026JP MorganMaintainedOverweightOverweight
May 11, 2026HC Wainwright & Co.MaintainedBuyBuy
May 7, 2026Wells FargoMaintainedOverweightOverweight
May 6, 2026StifelMaintainedBuyBuy
May 6, 2026Morgan StanleyMaintainedOverweightOverweight
May 6, 2026RBC CapitalMaintainedOutperformOutperform
May 5, 2026NeedhamMaintainedBuyBuy
Apr 10, 2026Wells FargoInitiated—Overweight
Apr 6, 2026BarclaysMaintainedOverweightOverweight
Mar 18, 2026MizuhoMaintainedOutperformOutperform
Mar 17, 2026JP MorganMaintainedOverweightOverweight
Mar 6, 2026UBSMaintainedNeutralNeutral
Feb 26, 2026Leerink PartnersMaintainedOutperformOutperform
Feb 25, 2026CitizensMaintainedMarket OutperformMarket Outperform
Feb 25, 2026NeedhamMaintainedBuyBuy